Journal article
Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection
Abstract
An efficacious Chlamydia vaccine is urgently needed to control Chlamydia infections. Heterologous prime-boost vaccination regimens are emerging as a promising strategy for preventing intracellular viral and bacterial infections. However, it remains to be determined if this regimen would be a feasible and effective approach for Chlamydia infection. In this study, we examined the immune response and the protective efficacy induced by various …
Authors
Brown THT; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock REW; Xing Z; Halperin SA; Wang J
Journal
Vaccine, Vol. 30, No. 2, pp. 350–360
Publisher
Elsevier
Publication Date
January 2012
DOI
10.1016/j.vaccine.2011.10.086
ISSN
0264-410X
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdenoviridaeAdjuvants, ImmunologicAdministration, IntranasalAnimalsAntibodies, BacterialAntigens, BacterialBacterial VaccinesChlamydia InfectionsChlamydia muridarumDrug CarriersFemaleGenetic VectorsImmunization, SecondaryLymphocytesMaleMiceMice, Inbred BALB CMice, Inbred C3HReproductive Tract InfectionsVaccinationVaccines, SubunitVaccines, Synthetic